Skip to main content
. 2023 Dec 7;3(3):361–367. doi: 10.1016/j.gastha.2023.11.020

Figure 2.

Figure 2

Imaging changes over time in type 3 AIP. Serial contrast-enhanced CTs of the abdomen and 1 representative patient before the start of immunotherapy in 4 months before the diagnosis of pancreatitis (A) at the time of diagnosis of immune mediated pancreatitis (B) and 1 year after the diagnosis of pancreatitis (C). (B) shows diffuse enlargement of the entire pancreas associated with peripancreatic stranding (arrows). (C) shows pancreatic volume loss without ductal dilatation or calcification or fatty replacement.